Key Takeaways
- Growth engines firing, 37% YoY revenue jump: Revenue grew 37% YoY and 38% sequentially as US customers shifted from destocking to restocking and Indian momentum held steady.
- Margins and working capital both improved sharply: Gross margin rose to 37% from 33% QoQ, EBITDA margin hit 11% (up 470 bps YoY), and net working capital days fell by 27 to 134 days.
- US plant loss nearly eliminated: The US subsidiary loss shrank from ₹14 crores to ~₹4 crores QoQ after shifting 45%-50% of its production to India, with the US revenue share now at 11%.
- Clean energy and new contracts are still ahead, not in the quarter: The clean energy storage ramp, new air segment 10-15 year contracts, and Kavach rail system are all expected to contribute in coming quarters, not Q2.
- What to watch next quarter: Whether the new customer ramp in clean energy and air begins to show in Q4 as guided, the pace of US breakeven, and any large contract wins management hinted are on the verge.
Revenue Growth & Restocking Cycle
- US restocking drove the quarter: US customers, who had been destocking, are now returning at varying rates, with some already above 100% of prior levels; US growth was 59% YoY.
- India business sustained momentum: Growth came from mobility, communication, and industrials, with rail and air as the fastest-growing segments and some defense work beginning.
- Destocking story is done: Management stated the destocking cycle is in its tail end, with customers returning to normal inventory rates and some placing larger orders for new products.
- Clean energy contribution is still minimal: The current quarter reflects very little clean energy revenue; the company is focused on battery storage (growing 60-70% YoY in the US), not solar panels or inverters, and the ramp is yet to begin.
- New customer ramp timeline: A clean energy product is fully tested and approved with first few hundred units in production now; meaningful contribution is expected in part of Q4 and more in Q1, supporting consistent growth in 2025.
- Air segment contracts signed: 10-15 year contracts in the air segment will start production late this quarter or in a month, with gradual scale-up next quarter; air and rail are likely the fastest-growing segments in the near term.
- Kavach rail system on the horizon: A customer has been approved by Indian railways for the Kavach system; interoperability testing is underway, and the opportunity may kick in during 2025, not in the next 3-4 months.
- Order book direction: Management stated the order book is only going to improve and noted they are on the verge of some large contracts but declined to give guidance until they materialize.
Bicha: "We actually do sometimes walk out of businesses. It's just, if we wanted to have growth at any cost, we would sign up any customer and we could have a much higher growth rate. I mean, we can have a debate on that. But we have taken the path of the longer-term customers with profitable growth."
US Operations Turnaround
- Production shift drove loss reduction: About 45%-50% of existing US production was moved to the India plant, cutting the US subsidiary loss from ₹14 crores in Q1 to ~₹4 crores in Q2 through cost rationalization and production allocation optimization.
- US revenue share fell sharply: US manufacturing revenue share decreased from 27% in Q1 FY24 to 11% in Q2 FY25, with the full-year mix expected around 85:15 (India:US).
- US strategy is dual-purpose: The US plant serves customers who either do not want to move production to India or cannot, such as quasi-military defense products or IRA-based products; management sees this as a competitive advantage.
- No breakeven threshold given: When asked what revenue level would make the US operations breakeven, management discussed the transition and cost actions but did not provide a specific revenue threshold.
- Policy risk is framed as an opportunity: If a new US administration mandates more domestic manufacturing, Avalon gains; if IRA benefits disappear, customers have the choice to switch production to India where Avalon offers a cost-effective alternative.
Bicha: "So, if there are certain businesses which cannot be moved outside the country, we stand to gain from that. And if the new administration decides to do more in the US, we are happy. The customers ultimately will make the choice at two different price levels, one at a higher cost in the US. So customers have both solutions today. And we are the only one positioned to do this in the Indian market today."
Margin & Operating Leverage
- Gross margin improved on product mix: Gross margins rose from 33% in Q1 to 37% in Q2, with the full year expected between 33% and 35% considering H2 revenue growth.
- Operating leverage became visible: EBITDA margins reached 11%, up 470 bps YoY, as most costs aside from material are fixed and revenue scaled; profit growth is expected to outpace revenue growth in coming quarters.
- India plant is highly profitable: The India plant, which now represents 89% of business, delivered an EBITDA margin of 13.7% and PAT margin of 8.7%, levels management described as sustainable over 5-10 years.
- Employee cost structure is inherently higher: Avalon carries a higher fixed cost base because it does mission-critical work requiring the best cadre employees, maintains a US side with higher costs, and performs total integration with box build at 50%-55% of what it does.
- No full-year margin guidance given: Management declined to provide margin guidance for the full year or confirm whether double-digit EBITDA margins are achievable comfortably this year, stating only that the operating leverage effect should sustain.
- Commodity risk is passed through: Some cost fluctuations are passed back to customers; gross margins were maintained at a stable 34%-35% even during COVID commodity volatility.
Balance Sheet & Capital Allocation
- Working capital improved significantly: Net working capital days reduced from 161 days (March 2024) to 134 days (September 2024), a 27-day improvement, primarily from better inventory management; net inventory days improved from 118 to 93.
- Historical target already exceeded: The company had previously targeted a 10-15 day improvement by March 2025 and has already achieved 27 days.
- Long-term working capital goal: The historical level is around 90 days, and management intends to move in that direction, though it will take time.
- Capex remains steady: The company expects to spend ₹40-45 crores per year for at least the next two years.
- ROCE ambition: Historically north of 20%, management intends to return there fairly soon through growth, operating leverage, working capital improvement, and margin improvement.
- Asset-light model goal: Management aims to maintain 8-10 times asset turns and run an asset-light model.
Bicha: "Historically, ROCEs have been north of 20%. We intend to get there fairly soon."
New Facilities & Segments
- New Chennai export plant operational: A new plant dedicated to export operations is complete and has begun production.
- Brownfield expansion on track: Phase 1 of the Chennai brownfield expansion is finished; Phase 2 is expected to start in H2 FY25 as planned.
- Rail segment deepening: Avalon signed a new customer in the rail segment and is seeing requirements for Indian railways in interlocking, braking, and cables, driven by domestic growth.
- Medical devices recovering: Growth in medical devices is driven by existing customers returning to full steam.
- High-performance computing still in progress: Work is ongoing with a partner, but management is waiting for releases and declined to provide a timeline, saying only that they will announce when it materializes.
- Deal wins across verticals: New business was signed in the railway vertical from a global leader, a box-build contract from a major industrial customer, and new orders in aerospace and communications.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 16% to 20% for FY25 | FY25 full year |
| Gross margin | 33% to 35% for full year | FY25 full year |
| US manufacturing share | Around 15% of revenue | FY25 full year |
| Revenue mix (India:US) | Around 85:15 | FY25 full year |
| Capex | ₹40-45 crores per year | Next two years at least |
| ROCE | Return to north of 20% | "Fairly soon" |
| Working capital | Move toward historical ~90 days (from 134) | No specific date; "will take time" |
| Clean energy new customer ramp | Start showing in part of Q4 and some in Q1 | Q4 FY25 / Q1 FY26 |
| Air segment contracts | Production starts late Q3 or in a month; gradual scale-up | Next quarter onward |
| Kavach rail system | May kick in | During 2025, not next 3-4 months |
| Revenue doubling ambition | Double revenue | Coming two to three years |
| India plant margin sustainability | 13.7% EBITDA, 8.7% PAT margins sustainable | 5-10 years |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Revenue | ₹275 cr, +37% YoY and +38% QoQ |
| Gross margin | 36.8%, down 0.21 ppt YoY from 37.1%; improved from 33% in Q1 FY25 |
| EBITDA | ₹30.1 cr, +140% YoY |
| EBITDA margin | 11.0%, up 470 bps YoY from 6.3% |
| PAT | ₹17.5 cr, +140% YoY |
| PAT margin | 6.3%, up 273 bps YoY from 3.5% |
| FY25 revenue growth guidance | 16% to 20% |
| Order book | ₹1,485 cr, +19.4% YoY, average execution period 14 months |
| Long-term contracts (14 months to 3 years) | ₹1,100 cr, +10.2% YoY |
| Net working capital days | 134 days, improved 27 days from 161 days in March 2024 |
| Net inventory days | 93 days, improved from 118 days in March 2024 |
| US manufacturing revenue share | 11%, down from 27% in Q1 FY24; anticipated ~15% for FY25 |
| US plant net loss | ~₹4 cr, improved from ₹14 cr loss in Q1 FY25 |
| India plant EBITDA margin | 13.7% (89% of business) |
| India plant PAT margin | 8.7% |
| Net cash position | ₹29.6 cr as of September 30, 2024 |
| Capacity utilization | 65%–70% on a two-shift basis |